Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor - Related Studies

Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor

This study is currently recruiting participants.

Study NCT00694330. Last updated on June 6, 2008. Information provided by Massachusetts General Hospital

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Glioma

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Neuroectodermal Tumors

3	Interventions listed in this trial
		GM-K562 Vaccination

4	Sponsors listed in this trial
		Massachusetts General Hospital
		Dana-Farber Cancer Institute
		Brigham and Women's Hospital